Cointime

Prospection

company

About

Leading provider of actionable real world evidence through artificial intelligence and machine learning technology.

  • 101 - 250

Highlights

Total Funding Amount
$45M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Corporate Round
Industries
Analytics,Artificial Intelligence,Big Data,Health Care,Information Technology,Machine Learning,Pharmaceutical,Predictive Analytics
Founded date
Jan 1, 2012
Number Of Employee
101 - 250
Operating Status
Active

Prospection is a Pioneer in healthcare data analytics. Using predictive analytics and machine learning with real world healthcare data to unearth insights that help research, develop and target better healthcare outcomes for patients. Founded out of Sydney’s Cicada Innovations in 2012, Prospection works with government, pharmaceutical companies and the medical community across more than 90 therapy programs, including immuno-oncology, Diabetes, Respiratory, HIV and hepatitis, in Australia, Japan, Asia Pacific, UK and USA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$45M
Prospection has raised a total of $45M in funding over 2 rounds. Their latest funding was raised on Jan 24, 2022 from a Corporate Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 24, 2022 Corporate Round — 1 — — Detail
Sep 13, 2021 Series B $45M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Prospection is funded by 1 investors. Novotech are the most recent investors.
Investor Name Lead Investor Funding Round
Novotech — Corporate Round
Cointime
Содержание
компания